D. E. Shaw & Co., Inc. Cin Cor Pharma, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$10.75 - $29.84 $1.43 Million - $3.96 Million	-132,681 Reduced 74.63%	45,094 $554,000
Q3 2022 Nov 14, 2022	BUY	$19.9 - $38.94 $3.19 Million - $6.24 Million	160,243 Added 914.0%	177,775 $5.84 Million
Q2 2022 Aug 15, 2022	SELL	$13.67 - $25.74 $238,186 - $448,493	-17,424 Reduced 49.85%	17,532 $330,000
Q1 2022 May 16, 2022	BUY	$14.13 - $28.49 $493,928 - $995,896	34,956 New	34,956 $613,000

Ticker CINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,764,300
Description
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.